A Phase 3, INterVentional, Double-Blind, Placebo-Control

Project: Research project

Project Details

Description

A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients with Advanced c-KIT/PDGFRA Gastrointestinal Stromal TUmorS who have Received Prior Treatment with Imatinib, Sunitinib, and/or Rego
StatusActive
Effective start/end date11/1/1711/30/20

Funding

  • DECIPHERA PHARMACEUTICALS, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.